Category: Press Release
C2 PHARMA Receives CEP approval for Latanoprost
C2 PHARMA Receives CEP approval for Oxybuprocaine Hydrochloride
C2 PHARMA Receives CEP Approval For Tropicamide
C2 PHARMA’s Upcoming Launch of Oxybuprocaine Hydrochloride
C2 PHARMA Receives DMF Approval in China for Pilocarpine Nitrate
C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona
EDQM Grants C2 PHARMA CEP Approval for Commercial Sale of Cyclopentolate Hydrochloride
C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API
C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio
C2 PHARMA Completes Multiple Regulatory Filings, Expands Portfolio
C2 PHARMA Acquires Digoxin API Portfolio from Nobilus Ent
Validation
C2 PHARMA leads
Acquisition
Willkommen zur deutschen Version von WordPress. Dies ist der erste Beitrag. Du kannst ihn bearbeiten oder löschen. Und dann starte mit dem Schreiben!